📌 Key Takeaways
- South Korea’s Ministry of Health and Welfare reported 2.01 million foreign medical visitors in 2025 — a record high for the third consecutive year, up 71.9% year-over-year.
- Japanese patients numbered approximately 600,000 (29.8% of total), ranking second after Chinese visitors (~620,000).
- Dermatology accounted for 62.9% of treatments — far exceeding plastic surgery (11.2%). Most visitors sought skin care, not surgical procedures.
- South Korea’s VAT refund program for cosmetic procedures ended December 31, 2025, and the weak yen is eroding the cost advantage.
- Post-return aftercare and treatment continuity remain underreported risks for medical tourists.
“I stopped by a dermatology clinic while I was in Seoul.”
This sentence has become routine in Japanese travel conversations.
Social media feeds are filled with posts like “got my skin done in Korea” or “had a treatment in Seoul,”
and aesthetic travel has quietly solidified into a cultural norm.
On April 24, 2026, South Korea’s Ministry of Health and Welfare released official figures
on foreign patient inflows for 2025.
The headline number: approximately 2.01 million foreign patients received medical care in South Korea in 2025 —
a record high, up 71.9% from the prior year.
Of those, roughly 600,000 were Japanese nationals, representing 29.8% of the total
and ranking second only to Chinese visitors (~620,000).
This is not a story about sightseeing with a side of skincare.
It is a story about what 600,000 people found in South Korea
that they could not — or did not — find at home.
INDEX
The Data in Full: 2.01 Million Visitors, Three Consecutive Record Years
(+71.9% YoY; third consecutive all-time record since tracking began in 2009)
(+36.0% YoY; #1 was China at ~620,000)
(Plastic surgery accounted for just 11.2%)
Source: South Korea Ministry of Health and Welfare, official release April 24, 2026 (data year: 2025).
Domestic Japanese coverage: Jiji Press, Nikkei Shimbun, Livedoor News, April 25–27, 2026.
The scale of growth is striking.
Since 2023, the annual patient count has roughly doubled each year.
And the composition of treatments challenges the popular image of “going to Korea for plastic surgery.”
The dominant category is dermatology — skin quality, texture, and tone improvement —
not surgical procedures.
Most of these 600,000 Japanese visitors were not seeking rhinoplasty or blepharoplasty.
They were seeking laser treatments, skin boosters, and regenerative injectables.
What Are They Getting? Most-Requested Treatments at Korean Dermatology Clinics
Per-session costs tend to be lower than in Japan, enabling multiple visits.
including formulations not yet approved in Japan.
A meaningful segment of visitors specifically seek treatments unavailable at home.
but if complications arise after returning home,
follow-up care at Japanese clinics may be refused.
Why Korea? The Structure Behind 600,000 Decisions
“It’s cheaper” is an incomplete explanation.
The data points to a more layered set of motivations.
are available in South Korea before regulatory approval in Japan.
For a segment of patients, the primary motivation is access, not price.
Board-certified dermatologists performing laser procedures in a competitive market
have developed high procedural volume and refined technique.
Many clinics are also experienced in serving international patients.
The idea of “visiting a Korean dermatologist” has been normalized through visible role models —
lowering the psychological barrier to action.
as part of a travel budget rather than a standalone medical expense.
With low-downtime procedures, sightseeing and skin care are not mutually exclusive.
2026 Shift: The “Korea Is Cheaper” Assumption Is Weakening
The cost calculus is changing — and the 2025 figures predate the most significant shift.
Foreign patients previously received a 10% VAT refund on aesthetic treatments.
That benefit no longer exists, reducing Korea’s price competitiveness.
When flights, accommodation, and treatment costs are totaled,
the all-in price may now equal — or exceed — equivalent treatment in Japan.
Whether volume holds in 2026 remains to be seen.
Non-price factors — treatment access, cultural affinity — will likely determine the answer.
When I first saw the 600,000 figure, my immediate question was not “why Korea” —
it was “what is Japan not providing?”
Price, treatment variety, clinical specialization, cultural momentum — all of it converges.
“They go because it’s cheap” cannot explain why the numbers kept rising
even after the VAT refund ended.
At the same time, the aftercare gap is a real and underreported problem.
When something goes wrong with a procedure done in Korea,
Japanese clinics frequently decline to treat it as a follow-up case.
Any honest account of medical tourism must include that risk.
NERO will continue reporting on both sides of this story.
Summary
- South Korea’s Ministry of Health and Welfare (official release: April 24, 2026) reported 2.01 million foreign patients in 2025 — up 71.9% YoY, the third consecutive all-time record since data collection began in 2009.
- Japanese nationals accounted for approximately 600,000 patients (29.8%, ranked #2); China ranked first at ~620,000. Japanese patient volume grew 36.0% year-over-year.
- Dermatology was the top specialty at 62.9% — far exceeding plastic surgery (11.2%). The dominant purpose was skin quality improvement, not surgical alteration.
- The reasons Japanese patients choose Korea are multifactorial: access to treatments not yet approved in Japan, high clinical density and specialization, K-beauty cultural influence, and the travel-treatment bundle model.
- South Korea’s VAT refund for cosmetic procedures ended December 31, 2025. Combined with the weak yen, the total cost of Korean aesthetic travel may now match or exceed domestic alternatives. The 2025 figures predate this shift; 2026 trends remain to be confirmed. Post-return aftercare risk is a critical factor that deserves equal attention.
Frequently Asked Questions
If a complication arises from a procedure performed in Korea,
Japanese clinics may decline to treat it as a follow-up, citing “treatment performed at another facility.”
If the procedure involved formulations not approved in Japan (e.g., PDRN, exosomes),
continued treatment or monitoring in Japan may be further restricted.
Before traveling, confirm the specific procedure, products used, and post-return care options.
Verify that the clinic is registered as a licensed foreign patient facility.
South Korea’s 10% VAT refund for cosmetic procedures ended December 31, 2025.
Combined with the weak yen, the all-in cost may now equal or exceed equivalent treatment in Japan.
Always compare total costs using current exchange rates and official clinic pricing before deciding.
Source: Radian Clinic Roppongi, “Recommended Korean Aesthetic Treatments 2026,” July 2026.
For procedures using Japan-approved products (e.g., botulinum toxin, hyaluronic acid fillers),
continuation at a Japanese clinic is generally possible — though it may be classified as a new case
with additional fees or potential refusal.
For treatments using non-approved formulations (PDRN, exosomes),
continued treatment or monitoring in Japan may be restricted.
Plan your post-return care strategy before you travel, not after.
Sources:
1. South Korea Ministry of Health and Welfare. “Foreign Patient Attraction Statistics.” Official release April 24, 2026 (data year: 2025).
2. Jiji Press. “Medical Tourism to Korea Hits Record High — Japanese Account for 30%.” April 27, 2026.
3. Nikkei Shimbun. “Korea’s Aesthetic Medicine Draws Foreign Visitors; Doctors Concentrated in Capital and Dermatology.” July 11, 2026.
4. Livedoor News. “Nearly One-Third Japanese: Foreign Patients in Korea Exceed 2 Million.” April 25, 2026.
5. Radian Clinic Roppongi. “Recommended Korean Aesthetic Treatments 2026.” July 2026.
